胰腺癌早期诊断研究现状及展望

李兆申

胰腺癌早期诊断研究现状及展望

李兆申

第二军医大学附属长海医院消化内科

详细信息

中图分类号: R735.9
计量
- 文章访问数: 3407
- HTML全文浏览量: 20
- PDF下载量: 755
- 被引次数: 0
出版历程
- 出版日期: 2010-05-20

Status and prospects of early diagnosis of pancreatic cancer

Li ZhaoShen

摘要

摘要: <正>近年来胰腺癌的发病率和病死率呈逐年上升趋势。胰腺癌早期诊断困难、预后极差,大多数胰腺癌诊断明确时已属中晚期。手术切除目前仍被认为是唯一可能根治胰腺癌的治疗方法。据美国SEER统计,2001年胰腺癌的总体5年生存率是5.2%,经根治性手术切除患者的5年生存率为18%,淋巴结阴性者为32%,切缘与淋巴结均为阴性者则是41%[1]。因此,寻求胰腺癌早期诊断方法可能是目前改善预后的关键。然而,目前尚无单一特异的早期诊断胰腺癌的方法。
- 胰腺肿瘤 /
- 早期诊断
- pancreatic neoplasms /
- early diagnosis

HTML全文

参考文献(23)

[1]Cameron JL, Riall TS, Coleman J, et al.One thousand consecutivepancreaticoduodenectomies[J].Ann Surg, 2006, 244 (1) ∶10-15.

[2]Brat DJ, Lillemoe KD, Yeo CJ, et al.Progression of pancreatic intra-ductal neoplasias to infiltrating adenocarcinoma of the pancreas[J].Am J Surg Pathol, 1998, 22 (2) ∶163-169.

[3]Pelaez-Luna M, Takahashi N, Fletcher JG, et al.Resectability ofpresymptomatic pancreatic cancer and its relationship to onset of di-abetes:a retrospective review of CT scans and fasting glucose valuesprior to diagnosis[J].Am J Gastroenterol, 2007, 102 (10) ∶2157-2163.

[4]Lynch SM, Vrieling A, Lubin JH, et al.Cigarette smoking and pan-creatic cancer:a pooled analysis from the pancreatic cancer cohortconsortium[J].Am J Epidemiol, 2009, 170 (4) ∶403-413.

[5]Lowenfels AB, Maisonneuve P, Cavallini G, et al.Pancreatitis andthe risk of pancreatic cancer[J].N Engl J Med, 1993, 328 (20) ∶1433-1437.

[6]Bracci PM, Wang F, Hassan MM, et al.Pancreatitis and pancreaticcancer in two large pooled case-control studies[J].Cancer CausesControl, 2009, 20 (9) ∶1723-1731.

[7]Chari ST, Leibson CL, Rabe KG, et al.Probability of pancreaticcancer following diabetes:a population-based study[J].Gastro-enterology, 2005, 129 (2) ∶504-511.

[8]Teich N.Pancreatic cancer:cause and result of diabetesmellitus[J].Gastroenterology, 2008, 134 (1) ∶344-345.

[9]Pannala R, Leibson CL, Rabe KG, et al.Temporal association ofchanges in fasting blood glucose and body mass index with diagnosisof pancreatic cancer[J].Am J Gastroenterol, 2009, 104 (9) ∶2318-2325.

[10]Senior K.Late-onset diabetes and the link with pancreaticcancer[J].Lancet Oncol, 2005, 6 (9) ∶641.

[11]Chari ST, Leibson CL, Rabe KG, et al.Pancreatic cancer-associat-ed diabetes mellitus:prevalence and temporal association with diag-nosis of cancer[J].Gastroenterology, 2008, 134 (1) ∶95-101.

[12]Klapman JB, Chang KJ, Lee JG, et al.Negative predictive value ofendoscopic ultrasound in a large series of patients with a clinicalsuspicion of pancreatic cancer[J].Am J Gastroenterol, 2005, 100 (12) ∶2658-2661.

[13]Horwhat JD, Paulson EK, McGrath K, et al.A randomized compari-son of EUS-guided FNA versus CT or US-guided FNA for the e-valuation of pancreatic mass lesions[J].Gastrointest Endosc, 2006, 63 (7) ∶966-975.

[14]Poley JW, Kluijt I, Gouma DJ, et al.The yield of first-time endo-scopic ultrasonography in screening individuals at a high risk of de-veloping pancreatic cancer[J].Am J Gastroenterol, 2009, 104∶2175-2181.

[15]Kim BJ, Lee KT, Moon TG, et al.How do we interpret an elevatedcarbohydrate antigen 19-9 level in asymptomatic subjects?[J].Dig Liver Dis, 2009, 41 (5) ∶364-369.

[16]Marten A, Buchler MW, Werft W, et al.Soluble iC3b as an earlymarker for pancreatic adenocarcinoma is superior to CA19.9 and ra-diology[J].J Immunother, 2010, 33 (2) ∶219-224.

[17]周国雄, 李兆申, 许国铭, 等.胰液K-ras 12密码子点突变检测对胰腺癌诊断的临床价值[J].第二军医大学学报, 2002, 23 (5) :477-479.

[18]Ohuchida K, Mizumoto K, Yamada D, et al.Quantitative analysis ofhuman telomerase reverse transcriptase in pancreatic cancer[J].Clin Cancer Res, 2006, 12 (7 Pt 1) ∶2066-2069.

[19]Lee EJ, Gusev Y, Jiang J, et al.Expression profiling identifies mi-croRNA signature in pancreatic cancer[J].Int J Cancer, 2007, 120 (5) ∶1046-1054.

[20]Wang J, Chen J, Chang P, et al.MicroRNAs in plasma of pancreaticductal adenocarcinoma patients as novel blood-based biomarkers ofdisease[J].Cancer Prev Res (Phila Pa) , 2009, 2 (9) ∶807-813.

[21]Ho AS, Huang X, Cao H, et al.Circulating miR-210 as a NovelHypoxia Marker in Pancreatic Cancer[J].Transl Oncol, 2010, 3 (2) ∶109-113.

[22]Gronborg M, Kristiansen TZ, Iwahori A, et al.Biomarker discoveryfrom pancreatic cancer secretome using a differential proteomic ap-proach[J].Mol Cell Proteomics, 2006, 5 (1) ∶157-171.

[23]Shen J, Person MD, Zhu J, et al.Protein expression profiles in pan-creatic adenocarcinoma compared with normal pancreatic tissue andtissue affected by pancreatitis as detected by two-dimensional gelelectrophoresis and mass spectrometry[J].Cancer Res, 2004, 64 (24) ∶9018-9026.

施引文献

资源附件(0)

访问统计